What You Need to Know (30-Second Summary)
- Embryo Chromosomes First: Visually flawless blastocysts can carry fatal aneuploidies; PGT-A genetic screening identifies chromosomally normal embryos.
- Chronic Endometritis (CD138): A silent bacterial inflammation of the uterine lining that prevents attachment, curable with a 14-day targeted antibiotic course.
- Diagnostic Hysteroscopy: High-magnification direct camera inspection of the cavity reveals subtle adhesions, micro-polyps, or septums missed on ultrasound.
- Window of Implantation: Adjusting the duration of progesterone exposure synchronizes the embryo with a displaced endometrial receptive window.
- Evidence-Based Immunology: Focus on proven clotting disorders like Antiphospholipid Syndrome with heparin/aspirin rather than costly unproven immune therapies.
Failing two embryo transfers does not mean your uterus is rejecting your baby. In seventy percent of failed transfers, chromosomes are the cause. The embryo stops developing. The uterus is not hostile.
Hearing a negative pregnancy test after transferring an ostensibly perfect embryo is devastating.
"Recurrent implantation failure is one of the most challenging scenarios in IVF, but it is not hopeless. A systematic investigation of embryo quality, uterine receptivity, and immunological factors often reveals addressable causes."
When it happens twice or three times, couples feel broken. They question their bodies. They wonder if their uterus is a hostile place.
What is Recurrent Implantation Failure? We define it when a woman under forty transfers embryos without success. Specifically: four cleavage embryos or two top-quality blastocysts. It is frustrating. It is emotionally exhausting.
The clinical reality is reassuring because human reproduction is naturally inefficient.
Even fertile couples have limits. Natural monthly conception chances are barely twenty-five percent.
When an IVF cycle fails, we do not guess. We do not repeat the exact same protocol hoping for luck.
We conduct a forensic investigation across three distinct biological domains: the embryo, the uterus, and maternal systemic factors.
The Embryonic Factor and Chromosomal Aneuploidy
The single greatest cause of implantation failure is embryonic chromosomal aneuploidy.
Inside the embryology laboratory, an embryologist grades embryos under an optical microscope based on appearance.
We look at cell symmetry. We check fragmentation percentage. We evaluate the expansion of the inner cell mass and trophectoderm. An embryo may receive a top morphological grade: 4AA or 5AA.
Visual grading cannot see chromosomes. It cannot detect DNA breaks.
A perfect 5AA blastocyst can carry severe genetic flaws. Missing chromosomes. Extra chromosomes. Unbalanced genes.
An aneuploid blastocyst can hatch. It can attach.
Between Day 5 and Day 8, the embryo activates its genetic engine. It tries to build organ systems.
Missing chromosomes stall cell division. The embryo arrests. It detaches. You get a negative result.
This is not a uterine failure. Nature halts non-viable life.
How do we solve this?
We recommend Preimplantation Genetic Testing for Aneuploidy, or PGT-A.
Our embryologist biopsies Day-5 blastocysts. We take five to eight cells from the outer ring. We do not touch the fetal mass. We analyze the DNA using Next-Generation Sequencing.
PGT-A identifies euploid embryos carrying the exact forty-six chromosomes required for normal life.
Transferring a euploid blastocyst jumps success to seventy percent. It removes genetic guesswork.
The Uterine Cavity and Endometrial Receptivity
If an embryo is genetically competent, our focus turns to the uterine environment.
An embryo requires a clean, receptive, and vascular cavity to anchor successfully.
We evaluate the uterine cavity using diagnostic hysteroscopy and high-resolution 3D ultrasound.
We search carefully for subtle structural obstacles inside the uterine cavity.
Polyps and fibroids act like foreign bodies. They distort the cavity. They release hostile chemicals. Hysteroscopy removes them cleanly in twenty minutes.
Intrauterine adhesions, or Asherman's syndrome, create scar tissue that bridges the uterine walls, obliterating vascular space. We lyse these adhesions under direct hysteroscopic visualization.
A uterine septum is a fibrous wall inside the womb. It lacks blood vessels. An embryo landing on it starves. Resecting the septum restores normal cavity space.
We also test for Chronic Endometritis.
Chronic endometritis is a silent uterine infection. It causes zero symptoms. No pain. No fever. No discharge.
Yet plasma cells fill the lining. They release inflammatory cytokines. They ruin receptivity.
We diagnose it with a gentle pipelle biopsy. We stain for CD138 plasma cells.
If positive, both partners take antibiotics for fourteen days. We use Doxycycline and Metronidazole. A repeat biopsy confirms clearance before transfer.
What about the Window of Implantation?
In roughly twenty percent of women with recurrent failure, the endometrium is healthy, but its receptivity timing is displaced.
The uterus has a narrow receptive window. It lasts thirty to forty-eight hours. We call it the Window of Implantation.
Standard frozen embryo transfer protocols schedule transfer after exactly one hundred and twenty hours of progesterone exposure.
Sometimes this window shifts. The lining might be pre-receptive. It needs extra progesterone hours. Or it might be post-receptive. It needs fewer hours.
We test this with an Endometrial Receptivity Analysis, or ERA. A mock cycle biopsy tests 248 genes. It pins down the exact transfer hour.
The Challenge of Thin Endometrium
In a subset of women with recurrent failure, the uterine cavity is structurally clear, but the endometrial lining refuses to grow.
For good implantation, we look for eight millimeters of thickness. We want a distinct triple-line pattern.
When the lining stays at five or six millimeters, implantation rates decline.
Thin linings often stem from previous curettage. Chronic pelvic infections also damage tissue. Poor blood flow plays a role.
When standard estrogen priming fails, we deploy advanced regenerative protocols.
Intrauterine Platelet-Rich Plasma (PRP) We often instill autologous platelet-rich plasma into the uterine cavity 48 hours before transfer to release growth factors that thicken stubborn endometrium.
We draw the patient's blood. We centrifuge it to concentrate platelets. Platelets carry rich growth factors.
We infuse this platelet concentrate into the uterus. We do this two days before starting progesterone.
PRP stimulates local capillary angiogenesis. It prompts endometrial cell proliferation. It enhances lining thickness.
Intrauterine G-CSF Infusion Infusing G-CSF stimulates local stem cell recruitment and enhances endometrial receptivity in chronically thin linings.
G-CSF is another powerful growth factor. It promotes vascular growth. It improves local immune tolerance. Infusing G-CSF helps refractory thin linings.
Vasoactive Therapies We add low-dose aspirin, pentoxifylline, and oral or vaginal sildenafil to enhance radial artery blood flow to the uterine lining.
We also add oral sildenafil or pentoxifylline. These medications dilate pelvic vessels. They increase blood velocity through radial arteries.
The Paternal Contribution and Sperm DNA Fragmentation
When embryo transfers repeatedly fail, clinical attention almost invariably focuses on the female partner.
This is a profound medical oversight.
The sperm contributes fifty percent of the genetic blueprint for the developing embryo.
Standard semen tests check count and motility. They cannot see DNA integrity. They miss internal fragmentation completely.
High Sperm DNA Fragmentation drives recurrent failure. A DNA Fragmentation Index above twenty-five percent is a major warning sign.
An egg can be fertilised by a sperm carrying fragmented DNA.
For three days, the embryo uses maternal egg energy.
However, between Day 3 and Day 4, a critical transition occurs: Embryonic Genome Activation.
On Day 3, paternal DNA wakes up.
If paternal DNA is broken, genes fail. Cell division halts. The embryo arrests before forming a blastocyst. Or it fails to implant.
We test sperm DNA using the Halosperm assay. We check the fragmentation index.
If the DFI is elevated, we treat the husband aggressively for three months prior to the next cycle.
We prescribe potent antioxidants. Coenzyme Q10. Vitamin C and E. Zinc and Selenium. These neutralize reactive oxygen species.
We screen for varicoceles with scrotal Doppler ultrasound. Microsurgical repair helps when veins are dilated.
We shorten the abstinence window to twenty-four hours before retrieval. This cuts epididymal oxidative stress drastically.
In the lab, we use Magnetic-Activated Cell Sorting, or MACS. MACS filters out dying sperm. We also use PICSI to pick mature sperm.
In severe cases, we use Testicular Sperm Aspiration, or TESA. Testicular sperm bypass the epididymis. They carry much lower DNA damage.
Maternal Systemic and Immunological Factors
When embryo quality and uterine cavity are optimal, we screen for maternal systemic conditions that impair microvascular perfusion.
Inherited and Acquired Thrombophilia Abnormal micro-clots in spiral arteries cut off blood supply to the implanting embryo. We test for antiphospholipid antibodies and Factor V Leiden, treating with low-molecular-weight heparin.
During implantation, developing trophoblast cells must connect with maternal blood vessels without forming microscopic blood clots.
In thrombophilia, tiny blood clots form at the transfer site. Blood supply cuts off. The embryo cannot anchor.
We test for Lupus Anticoagulant, Anticardiolipin antibodies, and Anti-beta-2-glycoprotein-1 antibodies.
We treat thrombophilia with low-dose aspirin and blood-thinning injections. Daily Clexane starts on transfer day.
Thyroid and Autoimmune Imbalances Elevated anti-TPO antibodies or high antinuclear antibodies trigger immune rejection of the embryo, managed with thyroid replacement and gentle corticosteroids.
Elevated TSH above 2.5 triggers pelvic inflammation. High anti-TPO antibodies impair implantation. We normalize TSH under 2.0 before transfer.
Toxic Fluid from Hydrosalpinx A blocked, fluid-filled fallopian tube leaks toxic fluid back into the uterine cavity, mechanically washing away embryos and poisoning the endometrium. Laparoscopic clipping or salpingectomy cures this completely.
A hydrosalpinx is a blocked, fluid-filled fallopian tube. It holds toxic fluid.
This fluid periodically leaks past into the uterine cavity.
This fluid leaks into the womb. It is embryotoxic. It washes away implanting embryos.
We clip or remove the blocked tube with laparoscopy. Removing toxic fluid doubles implantation rates.
A Strategic Roadmap Forward
Experiencing implantation failure is emotionally exhausting, but it is not the end of your parenthood hopes.
It is a signal to stop, investigate, and personalize your protocol.
We test embryonic chromosomes with PGT-A. We clear endometritis with antibiotics. We correct the uterine cavity. We personalize transfer timing. With this protocol, over eighty percent of couples achieve pregnancy within two transfers.
Do not lose hope. Science has answers for failed transfers.
The Challenge of Thin Endometrium
In a subset of women experiencing recurrent implantation failure, the uterine cavity is structurally normal, but the endometrial lining refuses to grow.
For good implantation, we look for eight millimeters of thickness. We want a distinct triple-line pattern.
When the lining remains stubbornly thin, measuring five or six millimeters despite high doses of oral and transdermal estradiol, implantation rates decline.
Thin endometrium often stems from previous vigorous curettage procedures after a miscarriage, chronic pelvic infections, or poor baseline uterine blood flow.
When standard estrogen priming fails, we deploy advanced regenerative protocols.
Intrauterine Platelet-Rich Plasma (PRP) We often instill autologous platelet-rich plasma into the uterine cavity 48 hours before transfer to release growth factors that thicken stubborn endometrium.
We draw the patient's blood. We centrifuge it to concentrate platelets. Platelets carry rich growth factors.
We infuse this platelet concentrate into the uterus. We do this two days before starting progesterone.
PRP stimulates local capillary angiogenesis, prompts endometrial stromal cell proliferation, and enhances endometrial thickness.
Intrauterine G-CSF Infusion Infusing G-CSF stimulates local stem cell recruitment and enhances endometrial receptivity in chronically thin linings.
G-CSF is a hematopoietic cytokine that stimulates local tissue remodeling, promotes vascular growth, and modulates local immune tolerance at the maternal-fetal interface. Infusing G-CSF into the uterine cavity has shown documented efficacy in improving lining thickness and clinical pregnancy rates in refractory thin lining cases.
Vasoactive Therapies We add low-dose aspirin, pentoxifylline, and oral or vaginal sildenafil to enhance radial artery blood flow to the uterine lining.
We also add oral sildenafil or pentoxifylline. These medications dilate pelvic vessels. They increase blood velocity through radial arteries.
The Paternal Contribution and Sperm DNA Fragmentation
When embryo transfers repeatedly fail, clinical attention almost invariably focuses on the female partner.
This is a profound medical oversight.
The sperm contributes fifty percent of the genetic and centrosomal blueprint for the developing embryo.
Standard semen tests check count and motility. They cannot see DNA integrity. They miss internal fragmentation completely.
High Sperm DNA Fragmentation drives recurrent failure. A DNA Fragmentation Index above twenty-five percent is a major warning sign.
An egg can be fertilised by a sperm carrying fragmented DNA.
During the first three days of development, the embryo runs primarily on maternal proteins and messenger RNA stored inside the egg cytoplasm.
However, between Day 3 and Day 4, a critical transition occurs: Embryonic Genome Activation.
On Day 3, paternal DNA wakes up.
If the paternal DNA strands are riddled with single-strand or double-strand breaks, the embryo cannot activate its developmental genes. Cell division halts. The embryo arrests before reaching the blastocyst stage, or forms a genetically compromised blastocyst that fails to implant.
We test sperm DNA using the Halosperm assay. We check the fragmentation index.
If the DFI is elevated, we treat the husband aggressively for three months prior to the next cycle.
We prescribe potent antioxidants. Coenzyme Q10. Vitamin C and E. Zinc and Selenium. These neutralize reactive oxygen species.
We screen for varicoceles with scrotal Doppler ultrasound. Microsurgical repair helps when veins are dilated.
We shorten the abstinence window to twenty-four hours before retrieval. This cuts epididymal oxidative stress drastically.
In the lab, we use Magnetic-Activated Cell Sorting, or MACS. MACS filters out dying sperm. We also use PICSI to pick mature sperm.
In severe cases, we use Testicular Sperm Aspiration, or TESA. Testicular sperm bypass the epididymis. They carry much lower DNA damage.
Investigating both partners systematically turns recurrent failure into successful pregnancy.
📚 Recommended Clinical Guides
Frequently Asked Questions About Recurrent Implantation Failure: Why IVF Isn't Working and What to Do
How many failed transfers define recurrent implantation failure?
Clinically, RIF means failing to conceive after transferring three high-grade cleavage embryos or two top-quality Day-5 blastocysts into a receptive uterus.
Does having an autoimmune disorder cause embryos to be rejected?
Most autoimmune conditions do not directly attack embryos. The uterus is naturally designed to welcome a genetically foreign embryo. Verified conditions like Antiphospholipid Syndrome impair placental blood flow, which we treat effectively with blood thinners.
Can PGT testing prevent implantation failure?
PGT-A screens blastocysts for correct chromosome numbers before transfer. While it cannot guarantee implantation, transferring a euploid blastocyst boosts per-transfer pregnancy rates to sixty-five percent and reduces miscarriage risk.
How does chronic endometritis differ from endometriosis?
Endometriosis is the presence of uterine-like tissue outside the uterus in the pelvic cavity. Chronic endometritis is a localized bacterial inflammation of the inner uterine lining itself, diagnosed via CD138 biopsy and cured with antibiotics.
Should we switch to a donor egg after repeated failures?
If repeated failures stem from severe egg aneuploidy, donor egg IVF offers pregnancy rates exceeding seventy percent. Young donor eggs provide strong genetic resilience.
Does embryonic genetic testing (PGT-A) help resolve recurrent implantation failure?
Yes. Over half of morphologically pristine blastocysts carry invisible chromosomal aneuploidies that prevent implantation. Testing embryos with PGT-A ensures we transfer only chromosomally normal euploid blastocysts, eliminating the primary cause of failure.
Can blood clotting disorders like Antiphospholipid Syndrome cause embryos to fail?
Yes. Thrombophilias and Antiphospholipid Syndrome (APS) create microscopic blood clots in tiny developing placental vessels, starving the embryo of oxygen. Daily low-dose aspirin and low molecular weight heparin injections overcome this barrier effectively.
Is an endometrial scratch beneficial for recurrent transfer failure?
Recent large randomized clinical trials show routine endometrial scratching does not significantly improve pregnancy rates in general IVF patients. We reserve targeted endometrial biopsies for evaluating CD138 chronic endometritis rather than mechanical scratching.
Can taking daily low-dose aspirin improve blood flow to the uterus in RIF?
Yes. Low-dose aspirin enhances uterine artery perfusion and reduces platelet aggregation. It promotes healthy trophoblastic invasion, supporting early embryo attachment.
The Path Forward: Taking Your Next Step with Confidence
Experiencing recurrent implantation failure—when multiple high-grade blastocysts fail to implant across repeated transfers—demands a systematic, scientific investigation rather than simply repeating identical protocols. Successful implantation requires synchronous alignment between embryo genetic competence and uterine endometrial receptivity.
Our clinical diagnostic workup addresses every potential barrier: evaluating uterine cavity architecture via 3D diagnostic hysteroscopy, ruling out chronic endometritis through CD138 plasma cell biopsy, screening for maternal thrombophilia and antiphospholipid antibodies, assessing paternal sperm DNA fragmentation, and considering Preimplantation Genetic Testing for Aneuploidy (PGT-A) to verify embryonic chromosomal balance.
Dr. Gunjan Gupta Govil has managed thousands of complex recurrent failure cases over 35 years of clinical practice. If you have experienced repeated failed transfers, visit Gunjan IVF World in Indirapuram, Noida Sector 49, Janakpuri, Greater Noida West, or Meerut for a comprehensive clinical audit and tailored implantation plan.